NatWest Group plc - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 174 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2015. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
NatWest Group plc ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2015$355,000
-62.2%
33,6940.0%0.01%
-33.3%
Q1 2015$939,000–33,694–0.01%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2015
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders